道诺霉素,20830-81-3，生产厂家，价格-洛克化工网移动版

返回



基本信息

制备方法及用途

物化性质

安全信息

毒理性

结构与计算化学

上游产品

下游产品

道诺霉素

中文名称：: 道诺霉素

中文别名：: 道诺霉素;
红保霉素

英文名称：: 5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-

英文别名：: daunorubicin;
fi6339;
daunamycin;
Cerubidine(R);
daunoxome;
DAUNOMYCIN;
cerubidin;
Daunorubicin;
rubomycinc

CAS No.：: 20830-81-3

分子式：: C₂₇H₂₉NO₁₀

分子量：: 527.52

精确分子量：: 527.17900

PSA：: 185.84000

EINECS：: 245-723-4

InChI：: InChI=1/C26H26O9.CH4.ClH.H3N.H2O.H2/c1-12(27)26(32)10-14-19(16(11-26)35-17-8-3-4-9-34-17)25(31)21-20(23(14)29)22(28)13-6-5-7-15(33-2)18(13)24(21)30;;;;;/h5-7,16-17,29,31-32H,3-4,8-11H2,1-2H3;1H4;1H;1H3;1H2;1H/t16-,17?,26-;;;;;/m0...../s13

危险品标志：

风险术语：: 3249;

安全术语：

分子结构式：

SDS：: 查看

道诺霉素物化性质

外观与性状：: 橙色-红色粉末
密度：: 1.554 g/cm3
熔点：: 155ºC
沸点：: 769.977ºC at 760 mmHg
闪点：: 419.467ºC
水溶解性：: Soluble
存储条件/存储方法：: 库房通风低温干燥,轻装轻卸、与氧化剂和酸类分开存放
稳定性相关：: 避免接触强氧化物
其它信息：: 1. 性状：未确定

2. 密度（g/mL,25/4℃）：未确定

3. 相对蒸汽密度（g/mL,空气=1）：未确定

4. 熔点（ºC）：未确定

5. 沸点（ºC,常压）：未确定

6. 沸点（ºC,5.2kPa）：未确定

7. 折射率：未确定

8. 闪点（ºC）：未确定

9. 比旋光度（º）：未确定

10. 自燃点或引燃温度（ºC）：未确定

11. 蒸气压（kPa,25ºC）：未确定

12. 饱和蒸气压（kPa,60ºC）：未确定

13. 燃烧热（KJ/mol）：未确定

14. 临界温度（ºC）：未确定

15. 临界压力（KPa）：未确定

16. 油水（辛醇/水）分配系数的对数值：未确定

17. 爆炸上限（%,V/V）：未确定

18. 爆炸下限（%,V/V）：未确定

19. 溶解性：未确定

道诺霉素安全信息

包装等级：
III

风险类别：
6.1(b)

危险类别码：
R3249

道诺霉素毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HB7875000

CHEMICAL NAME :
Daunomycin

CAS REGISTRY NUMBER :
20830-81-3

LAST UPDATED :
199806

DATA ITEMS CITED :
159

MOLECULAR FORMULA :
C27-H29-N-O10

MOLECULAR WEIGHT :
527.57

WISWESSER LINE NOTATION :
L E6 C666 BV MVT&&&J DQ HV1 HQ KQ RO1 FO- FT6OTJ B1 CQ DZ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Human

DOSE/DURATION :
6 mg/kg

TOXIC EFFECTS :
Cardiac - other changes

TYPE OF TEST :
LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Human - child

DOSE/DURATION :
10 mg/kg/30D-I

TOXIC EFFECTS :
Cardiac - cardiomyopathy including infarction

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
336 mg/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
20 mg/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Subcutaneous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
33200 ug/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
13 mg/kg

TOXIC EFFECTS :
Blood - other changes Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Oral

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
205 mg/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
2500 ug/kg

TOXIC EFFECTS :
Gastrointestinal - other changes

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
8600 ug/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Unreported

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
24900 ug/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Mammal - dog

DOSE/DURATION :
4 mg/kg

TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rabbit

DOSE/DURATION :
5 mg/kg

TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - guinea pig

DOSE/DURATION :
6 mg/kg

TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Subcutaneous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
500 ug/kg/5W-I

TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
27 mg/kg/9D-I

TOXIC EFFECTS :
Blood - changes in bone marrow (not otherwise specified) Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
10 mg/kg/5D-I

TOXIC EFFECTS :
Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Subcutaneous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
55500 ug/kg/5D-I

TOXIC EFFECTS :
Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
31000 ug/kg/2D-I

TOXIC EFFECTS :
Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
50 mg/kg/2W-I

TOXIC EFFECTS :
Blood - changes in bone marrow (not otherwise specified) Blood - changes in spleen Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Mammal - dog

DOSE/DURATION :
10 mg/kg/10D-I

TOXIC EFFECTS :
Gastrointestinal - changes in structure or function of endocrine pancreas Blood - leukopenia Blood - changes in bone marrow (not otherwise specified)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Mammal - dog

DOSE/DURATION :
30 mg/kg/15W-I

TOXIC EFFECTS :
Kidney, Ureter, Bladder - inflammation, necrosis, or scarring of bladder Blood - changes in bone marrow (not otherwise specified) Blood - changes in spleen

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Primate - monkey

DOSE/DURATION :
7 mg/kg/14D-I

TOXIC EFFECTS :
Lungs, Thorax, or Respiration - chronic pulmonary edema Liver - other changes Skin and Appendages - dermatitis, other (after systemic exposure)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Primate - monkey

DOSE/DURATION :
15 mg/kg/27D-I

TOXIC EFFECTS :
Blood - normocytic anemia Blood - leukopenia Skin and Appendages - dermatitis, other (after systemic exposure)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rabbit

DOSE/DURATION :
51 mg/kg/9W-I

TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - changes in platelet count Nutritional and Gross Metabolic - changes in calcium

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rabbit

DOSE/DURATION :
61200 ug/kg/11W-I

TOXIC EFFECTS :
Cardiac - EKG changes not diagnostic of specified effects Related to Chronic Data - death

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
2200 ug/kg/7W-I

TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumor types after systemic administration not seen spontaneously

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
6250 ug/kg

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
2340 ug/kg/26W-I

TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Blood - lymphoma, including Hodgkin's disease

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Subcutaneous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
15 gm/kg/12W-I

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
5 mg/kg

TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Reproductive - Tumorigenic effects - other reproductive system tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
13 mg/kg

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
10 mg/kg

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Skin and Appendages - tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
40 mg/kg/4W-I

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
10 mg/kg

TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Intravenous

SPECIES OBSERVED :
Rodent - rat

DOSE/DURATION :
5 mg/kg

TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors

TYPE OF TEST :
TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :
Subcutaneous

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
15 mg/kg/12W-I

TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Tumorigenic - tumors at site of application

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

DOSE :
16 mg/kg

SEX/DURATION :
female 7-14 day(s) after conception

TOXIC EFFECTS :
Reproductive - Fertility - abortion

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

DOSE :
9 mg/kg

SEX/DURATION :
female 7-9 day(s) after conception

TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

DOSE :
8 mg/kg

SEX/DURATION :
female 7-14 day(s) after conception

TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - urogenital system

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

DOSE :
4 mg/kg

SEX/DURATION :
female 6-9 day(s) after conception

TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intraperitoneal

DOSE :
16 mg/kg

SEX/DURATION :
female 6-9 day(s) after conception

TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - gastrointestinal system

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Subcutaneous

DOSE :
35 mg/kg

SEX/DURATION :
female 7 day(s) pre-mating female 1-21 day(s) after conception

TOXIC EFFECTS :
Reproductive - Maternal Effects - postpartum

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

DOSE :
2200 ug/kg

SEX/DURATION :
male 1 day(s) pre-mating

TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :
TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :
Intravenous

DOSE :
1500 ug/kg

SEX/DURATION :
female 1-15 day(s) after conception

TOXIC EFFECTS :
Reproductive - Fertility - abortion

TYPE OF TEST :
DNA inhibition

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Micronucleus test

TYPE OF TEST :
DNA damage

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Micronucleus test

TYPE OF TEST :
DNA adduct

TYPE OF TEST :
Mutation test systems - not otherwise specified

TYPE OF TEST :
Mutation test systems - not otherwise specified

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Cytogenetic analysis

TYPE OF TEST :
Sister chromatid exchange

TYPE OF TEST :
Sister chromatid exchange

TYPE OF TEST :
Sperm Morphology
MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis

TEST SYSTEM :
Mammal - cattle Sperm

DOSE/DURATION :
1 mg/L

REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 326,185,1995 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 10,145,1976 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 10,145,1976 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW 32XPAD "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 Volume(issue)/page/year: -,49,1975 TOXICOLOGY REVIEW 32XPAD "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 Volume(issue)/page/year: -,49,1975 TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 2,159,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4587 No. of Facilities: 146 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 3047 (estimated) No. of Female Employees: 1170 (estimated)

道诺霉素分子结构与计算化学数据

分子结构数据

1、   摩尔折射率：129.98

2、   摩尔体积(m³/mol)：339.4

3、   等张比容(90.2K)：1037.9

4、   表面张力(dyne/cm)：87.4

5、   极化率(10-24cm³)：51.52

计算化学数据

1.疏水参数计算参考值（XlogP）:无
2.氢键供体数量:5
3.氢键受体数量:11
4.可旋转化学键数量:4
5.互变异构体数量:54
6.拓扑分子极性表面积186
7.重原子数量:38
8.表面电荷:0
9.复杂度:960
10.同位素原子数量:0
11.确定原子立构中心数量:6
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1

道诺霉素上游产品

盐酸柔红霉素 (8S,10S)-8-乙酰基-7,8,9,10-四氢-6,8,11-三羟基-1-甲氧基-10-[[2,3,6-三脱氧-3-[[[[4-(BETA-D-吡喃半乳糖基氧基)-3-硝基苯基]甲氧基]羰基]氨基]-ALPHA-L-来苏-己糖吡喃糖苷]氧基]-5,12-并四苯醌

道诺霉素下游产品

洋红霉素酮柔红霉素柔红酮 (8R)-8-乙酰基-7,8,9,10-四氢-6,8,11-三羟基-1-甲氧基-5,12-并四苯醌 N-[6-[(3-乙酰基-3,5,12-三羟基-10-甲氧基-6,11-二氧代-2,4-二氢-1H-并四苯-1-基)氧基]-3-羟基-2-甲基四氢吡喃-4-基]乙酰胺

推荐供应商

山东默派生物科技有限公司

道诺霉素
联系人：谭经理
电  话：13053322091
手  机：13053322091
Cas号：20830-81-3
包装：1kg
纯度：99%
价格：洽谈
杭州鼎燕化工有限公司

柔红霉素
联系人：任
电  话：0571-87157530
手  机：18049756717
Cas号：20830-81-3
包装：1kg
纯度：99%
价格：100.0元
上海启太生物科技有限公司

柔红霉素杂质
联系人：肖经理
电  话：176-21686100
手  机：17621686100
Cas号：20830-81-3
包装：25mg支
纯度：95%
价格：洽谈
钟祥市耀威生物科技有限公司，
柔红霉素
联系人：汪
电  话：13260682861
手  机：13260682861
Cas号：20830-81-3
包装：1kg,25kg,1kg
纯度：99%
价格：洽谈
钟祥市耀威生物科技有限公司

20830-81-3柔红霉素
联系人：李经理
电  话：15337241005
手  机：15337241005
Cas号：20830-81-3
包装：1kg,1kg,1kg
纯度：99%
价格：洽谈
湖北魏氏化学试剂股份有限公司

道诺霉素
联系人：刘涛
电  话：027-59101766
手  机：13125137661
Cas号：20830-81-3
包装：洽谈
纯度：
价格：洽谈
郑州森海化工产品有限公司

柔红霉素
联系人：李冰
电  话：0371-55620010
手  机：15237158109
Cas号：20830-81-3
包装：洽谈
纯度：
价格：洽谈
武汉荆楚医药化工有限公司

柔红霉素
联系人：zhanglele1014
电  话：027-88877052
手  机：13871372440
Cas号：20830-81-3
包装：洽谈
纯度：
价格：洽谈
台州市晟欣医药化工有限公司 (原名台州市椒江星成医药化工有限公司)
道诺霉素
联系人：陆
电  话：0576-88886292,88551200,88525005
手  机：
Cas号：20830-81-3
包装：洽谈
纯度：
价格：洽谈
句容市兴春化工有限公司

柔红霉素
联系人：许其民
电  话：0511-87871122
手  机：13905182802
Cas号：20830-81-3
包装：洽谈
纯度：
价格：洽谈

道诺霉素

道诺霉素制备方法及用途

制备方法

合成制备方法

用途简介

用途

道诺霉素物化性质

道诺霉素安全信息

道诺霉素毒理性

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

道诺霉素分子结构与计算化学数据

分子结构数据

计算化学数据

道诺霉素上游产品

道诺霉素下游产品

推荐供应商

山东默派生物科技有限公司

道诺霉素

杭州鼎燕化工有限公司

柔红霉素

上海启太生物科技有限公司

柔红霉素杂质

钟祥市耀威生物科技有限公司，

柔红霉素

钟祥市耀威生物科技有限公司

20830-81-3柔红霉素

湖北魏氏化学试剂股份有限公司

道诺霉素

郑州森海化工产品有限公司

柔红霉素

武汉荆楚医药化工有限公司

柔红霉素

台州市晟欣医药化工有限公司 (原名台州市椒江星成医药化工有限公司)

道诺霉素

句容市兴春化工有限公司

柔红霉素

道诺霉素

道诺霉素 制备方法及用途

制备方法

合成制备方法

用途简介

用途

道诺霉素 物化性质

道诺霉素 安全信息

道诺霉素 毒理性

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

道诺霉素 分子结构与计算化学数据

分子结构数据

计算化学数据

道诺霉素 上游产品

道诺霉素 下游产品

推荐供应商

山东默派生物科技有限公司

道诺霉素

杭州鼎燕化工有限公司

柔红霉素

上海启太生物科技有限公司

柔红霉素杂质

钟祥市耀威生物科技有限公司，

柔红霉素

钟祥市耀威生物科技有限公司

20830-81-3柔红霉素

湖北魏氏化学试剂股份有限公司

道诺霉素

郑州森海化工产品有限公司

柔红霉素

武汉荆楚医药化工有限公司

柔红霉素

台州市晟欣医药化工有限公司 (原名台州市椒江星成医药化工有限公司)

道诺霉素

句容市兴春化工有限公司

柔红霉素

道诺霉素制备方法及用途

道诺霉素物化性质

道诺霉素安全信息

道诺霉素毒理性

道诺霉素分子结构与计算化学数据

道诺霉素上游产品

道诺霉素下游产品